WHITE, H., F. LIN, A. AGGERHOLM, H. ANDRIKOVICS, G. BARBANY, N. BOECKX, JM. CAYUELA, D. COLOMER, F. DARAIO, S. DULUCQ, El HOUSNI, G. GERRARD, E. GINEIKIENE, S. HAYETTE, B. IZZO, M. JANSSON, P. JOHNELS, Tomáš JURČEK, V. KAIRISTO, T. LANGE, T. LION, Kateřina MACHOVÁ POLÁKOVÁ, G. MARTINELLI, PA MERLE, G. MITTERBAUER-HOHENDANNER, M. NAGAR-MARCIANO, J. NOMDEDEU, D. NYMOEN, E. OPPLIGER LEIBUNDGUT, U. OZBEK, T. PAJIC, C. PREUDHOMME, K. RAUDSEPP, T. SACHA, R. TALMACI, T. TOULOUMENIDOU, VHJ. VAN DER VELDEN, R. ZADRO, J. ZIERMANN, K. ZOI, MC MULLER, A. HOCHHAUS and NCP. CROSS. Defining low and undetectable levels of disease in chronic myeloid leukaemia: progress towards standardisation in europe. In 18th Congress of the European Hematology Association in Haematologica. 2013.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Defining low and undetectable levels of disease in chronic myeloid leukaemia: progress towards standardisation in europe
Authors WHITE, H., F. LIN, A. AGGERHOLM, H. ANDRIKOVICS, G. BARBANY, N. BOECKX, JM. CAYUELA, D. COLOMER, F. DARAIO, S. DULUCQ, El HOUSNI, G. GERRARD, E. GINEIKIENE, S. HAYETTE, B. IZZO, M. JANSSON, P. JOHNELS, Tomáš JURČEK, V. KAIRISTO, T. LANGE, T. LION, Kateřina MACHOVÁ POLÁKOVÁ, G. MARTINELLI, PA MERLE, G. MITTERBAUER-HOHENDANNER, M. NAGAR-MARCIANO, J. NOMDEDEU, D. NYMOEN, E. OPPLIGER LEIBUNDGUT, U. OZBEK, T. PAJIC, C. PREUDHOMME, K. RAUDSEPP, T. SACHA, R. TALMACI, T. TOULOUMENIDOU, VHJ. VAN DER VELDEN, R. ZADRO, J. ZIERMANN, K. ZOI, MC MULLER, A. HOCHHAUS and NCP. CROSS.
Edition 18th Congress of the European Hematology Association in Haematologica, 2013.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30200 3.2 Clinical medicine
Confidentiality degree is not subject to a state or trade secret
Organization unit Central European Institute of Technology
Tags International impact, Reviewed
Changed by Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 8/1/2014 21:58.
PrintDisplayed: 27/7/2024 22:14